About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

O relatório

Notícias verificadas sobre financiamento, sedes e liderança das empresas mais inovadoras do mundo

7 relatórios e mais

Atualizado diariamente com as últimas inteligências de mercado
Fundraising
Celgene

Celgene Raises $90B in Public

Celgene, a Biotech company based in 86 Morris Avenue, Summit, NJ 07901, has raised $90B in Public at a $95B valuation led by Bristol Myers Squibb.

Fundraising News Team
Jan 1, 2024
0 min read
Biotech
Celgene

Celgene raises $90B Public at $95B valuation

Celgene raises $90B in Public at $95B valuation. Biotechnology company...

Editorial Team
Jan 1, 2024
0 min read•$90B
Venture Capital
Celgene Ventures

Celgene Ventures Headquarters - Office Location & Address

Discover Celgene Ventures's headquarters at 86 Morris Ave, Summit, NJ 07901. Investment arm of Celgene backing early-stage biotechnology and pharmaceutical companies. Focus on oncology, immunology, inflammation, and cell therapy innovations.

Editorial Team
Oct 6, 2025
0 min read
Biotechnology
Celgene

Celgene Headquarters - Office Location & Address

Discover Celgene's headquarters at 86 Morris Ave, Summit, NJ 07901. Biopharmaceutical therapies. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Biotechnology
Celgene Corporation

Celgene Corporation Headquarters - Office Location & Address

Discover Celgene Corporation's headquarters at 86 Morris Ave, Summit, NJ 07901. Biopharmaceutical company. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Fundraising
Evelo Biosciences

Evelo Biosciences Raises $75M in Series D

Evelo Biosciences, a Biotech company based in 620 Memorial Drive, Cambridge, MA 02139, has raised $75M in Series D at a $500M valuation led by Fidelity, Celgene, Kaiser Permanente Ventures, Flagship Pioneering.

Fundraising News Team
Aug 5, 2024
0 min read
Biotech
Evelo Biosciences

Evelo Biosciences raises $75M Series D at $500M valuation

Evelo Biosciences raises $75M in Series D at $500M valuation. Monoclonal microbials for cancer and inflammation...

Editorial Team
Aug 5, 2024
0 min read•$75M
Página 1

Mostrando 7 relatórios • Página 1 • Categoria: all

Fique à frente do mercado

Receba insights semanais em sua caixa de entrada. Sem spam, apenas inteligência.